FOXA
55
9
PNW
66
3
KMX
58
3
V
60
-6
LLY
39
9
VLO
40
-2
INTC
35
-2
FDX
36
-4
AMP
69
-3
M
20
-4
HRB
51
2
XEL
67
2
COP
56
2
ICE
59
-3
BA
52
2
HRL
39
15
WMT
74
2
MDLZ
34
2
AES
39
-4
EXC
54
-2
FOXA
55
9
PNW
66
3
KMX
58
3
V
60
-6
LLY
39
9
VLO
40
-2
INTC
35
-2
FDX
36
-4
AMP
69
-3
M
20
-4
HRB
51
2
XEL
67
2
COP
56
2
ICE
59
-3
BA
52
2
HRL
39
15
WMT
74
2
MDLZ
34
2
AES
39
-4
EXC
54
-2
Financhill
Back

Aurinia Pharmaceuticals Quote, Financials, Valuation and Earnings

Invest. Do Good. Get Rewarded. Just $0.25/Share!

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
62

AUPH
Aurinia Pharmaceuticals

Last Price:
8.77
Seasonality Move:
24.51%

7 Day Trial

ALL ACCESS PASS

$ 7

Access The Stock Grader Trading Tool From "The King Of Quants"

More details here...

Aurinia Pharmaceuticals Price Quote

$8.77
+0.53 (+6.43%)
(Updated: November 21, 2024 at 5:55 PM ET)

Aurinia Pharmaceuticals Key Stats

Buy
62
Aurinia Pharmaceuticals (AUPH) is a Buy
Day range:
$7.91 - $8.26
52-week range:
$4.71 - $10.05
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
5.25
P/B ratio:
2.96%
Volume:
1.3M
Avg. volume:
1.2M
1-year change:
-10.82%
Market cap:
$1.1B
Revenue:
$175.5M
EPS:
$-0.14

How Much Does Aurinia Pharmaceuticals Make?

Is Aurinia Pharmaceuticals Growing As A Company?

Aurinia Pharmaceuticals Stock Price Performance

What Is Aurinia Pharmaceuticals 52-Week High & Low?

Aurinia Pharmaceuticals Price To Free Cash Flow

Is It Risky To Buy Aurinia Pharmaceuticals?

Is Aurinia Pharmaceuticals Cash Flow Positive?

  • What Is AUPH Cash Flow From Operations?
    Cash flow from operations (TTM) is $28.6M
  • What Is Aurinia Pharmaceuticals’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$31.6M
  • What Is Aurinia Pharmaceuticals’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$6.2M

Aurinia Pharmaceuticals Return On Invested Capital

  • Is Management Doing A Good Job?
    AUPH return on invested capital is -5.99%
  • What Is Aurinia Pharmaceuticals Return On Assets?
    ROA measures how assets are converting to revenues and is -4.19%
  • What Is AUPH Return On Equity?
    ROE is a measure of profitability and is -5.99%

Aurinia Pharmaceuticals Earnings Date & Stock Price

Aurinia Pharmaceuticals Competitors

Aurinia Pharmaceuticals Dividend Yield

Aurinia Pharmaceuticals Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 566.67%
Revenue: 24.32% 17.47%

Analyst Recommendations

Buy Recommendations: 3
Hold Recommendations: 1
Sell Recommendations: 0
Price Target: 10.84
Upside from Last Price: 31.5%

Major Shareholders

  • How many AUPH shares are owned by institutional investors?
    78.1M AUPH shares are owned by institutional investors
  • How many AUPH shares are owned by insiders?
    4.6M AUPH shares are owned by insiders